Scancell AGM: Shareholders Approve All Resolutions Amid Uncertain Biotech Outlook
Scancell Holdings PLC’s AGM confirms shareholder approval, yet investors weigh early‑stage ImmunoBody® successes against a steep P/E‑loss and market doubts. This deep dive explores the biotech’s pipeline, partnerships, and financial risks for those …
2 minutes to read
